Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Antibiotics
- Balanced Salt Solutions
- Cell Dissociation Reagents
- Cell Freezing Media
- Cell Health Assays
- Cell Identification Service
- Cell Lines
- Complete Growth Media
- Cytokines
- Exosome Isolation Kits
- Growth Supplements
- Induced Differentiation Media
- Liquid Basal Media
- Other Reagents
- Others
- Powder Basal Media
- Primary Cell Isolation and Culture Kit
- Primary Cell Isolation and Culture Kits
- Primary Cells
- Removal Media
- Removal Reagents
- Serum
- Serum-Free Media
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cuba
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Kyrgyzstan
- Luxembourg
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Nigeria
- Norway
- Oman
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 33,514 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Discovery of a small molecule RIOK1 inhibitor CINS-1 against colorectal cancer via disrupting ribosomal biosynthesis (2026-07-08)
Journal: Acta Pharmaceutica Sinica B (2026) IF: 14.6Products Cited: Fetal Bovine Serum -
Neutrophil mediated BDNF delivery for the treatment of moderate to severe Alzheimer’s disease (2026-07-10)
Journal: Acta Pharmaceutica Sinica B (2026) IF: 14.6Products Cited: -
CMTM6 maintains B cell-intrinsic membrane CD40 stability to regulate anti-tumor immunity (2026-07-15)
Journal: Acta Pharmaceutica Sinica B (2026) IF: 14.6Products Cited: -
Microglial LNK regulates metabolic reprogramming via competitively inhibiting OTUB1 binding to PKM2 and mitigates ischemic stroke (2026-07-25)
Journal: Acta Pharmaceutica Sinica B (2026) IF: 14.6Products Cited: -
A peptide-based nano-PROTAC synergistically driving ferroptosis-immunotherapy in triple-negative breast cancer (2026-07-31)
Journal: Acta Pharmaceutica Sinica B (2026) IF: 14.6Products Cited: -
Identification of flupirtine as a candidate against liver fibrosis in mice: Preserving mitochondria quality by suppressing calpain 1/complex I/mtROS axis via targeting asparagine synthase (2026-08-21)
Journal: Acta Pharmaceutica Sinica B (2026) IF: 14.6Products Cited: Mouse Hepatic Stellate Cells -
Activation of KIF18B-MYC axis by autophagic CUL3 degradation promotes copper imbalance essential for gastric cancer progression (2026-08-31)
Journal: Acta Pharmaceutica Sinica B (2026) IF: 14.6Products Cited: Fetal Bovine Serum -
Targeting the USP13–ACLY axis in tumor endothelial cells: Ginsenoside Rd suppresses pathological angiogenesis through metabolic-epigenetic reprogramming (2026-09-05)
Journal: Acta Pharmaceutica Sinica B (2026) IF: 14.6Products Cited: -
Targeted delivery of siIKKβ and siG12D by nucleotidyl and mannosylated peptidyl lipids regulates macrophage repolarization and tumor cell metabolism for cancer therapy (2026-09-08)
Journal: Acta Pharmaceutica Sinica B (2026) IF: 14.6Products Cited: RPMI-1640 Medium -
mtROS-bursting, acidity-neutralizing micelle boost and stabilize tumor NKG2D ligands for enhanced immunotherapy (2026-09-24)
Journal: Acta Pharmaceutica Sinica B (2026) IF: 14.6Products Cited:
